Lowering blood levels of the amino acid tryptophan, a precursor to the chemical messenger serotonin, changes how the autism brain responds to emotions, according to a report published 4 June in PLoS One.
Spectrum: Autism Research News
Children who receive a combination of melatonin and behavioral therapy fall asleep faster and have better sleep quality than those who get either treatment alone or those on placebo, according to a study published 22 May in the Journal of Sleep Research.
By manipulating the location of a protein that detects capsaicin, the molecule responsible for the burn in hot chili peppers, researchers can activate subpopulations of neurons and alter the behavior of mice. The results were published 20 March in Nature Communications.
An autism-associated variant in a gene that regulates the chemical messenger serotonin leads to abnormal serotonin regulation and autism-like behaviors in mice. The results were published 3 April in the Proceedings of the National Academy of Sciences.
Fluoxetine, an antidepressant marketed as Prozac, may alleviate repetitive behaviors in adults with autism, according to a study published 2 December in the American Journal of Psychiatry.
A subset of people with autism have genetic and biochemical abnormalities in a sleep-related enzyme, according to research presented Friday at a satellite conference of the Society for Neuroscience annual meeting in Washington, D.C.
Mouse pups with a duplication of GTF2I, a gene linked to Williams syndrome and autism, show extreme separation anxiety when separated from their mothers, according to unpublished findings presented Thursday at the International Congress of Human Genetics in Montreal, Canada.
Researchers have engineered four new mouse lines that each show activation of a different subset of neurons in response to a blue light.
A protein that regulates the development of serotonin-producing neurons in the brain is associated with autism.
The first study to sequence more than 100 genes on the X chromosome in people with autism or schizophrenia has turned up some promising leads.